Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort

BACKGROUND: Despite the introduction of direct-acting antiviral agents for chronic hepatitis C virus (HCV) infection, peginterferon alfa/ribavirin remains relevant in many resource-constrained settings. The non-randomized GUARD-C cohort investigated baseline predictors of safety-related dose reducti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Foster, Graham R., Coppola, Carmine, Derbala, Moutaz, Ferenci, Peter, Orlandini, Alessandra, Reddy, K. Rajender, Tallarico, Ludovico, Shiffman, Mitchell L., Ahlers, Silke, Bakalos, Georgios, Hassanein, Tarek
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4809570/
https://ncbi.nlm.nih.gov/pubmed/27018988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0151703
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados